The Global Fund invests up to US$5 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all.
We unite the world to find solutions that have the most impact, and we take them to scale worldwide. It’s working. We won’t stop until the job is finished.
News
-
14 April 2026
U.S. and Global Fund Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates
-
27 March 2026
Global Fund Approves Emergency TB Funding for Conflict-affected Sudan
-
16 March 2026
Grant Cycle 8 Update
-
18 February 2026
Global Fund Board Welcomes Final Eighth Replenishment Outcome of US$12.64 Billion, Backs Strategic Shifts to Advance Countries’ Path to Self-Reliance
-
04 February 2026
Global Fund Launches Process to Select New Executive Director
-
02 February 2026
Global Fund Appoints Philippa Bonay as Chief Human Resources Officer
